|
Global X Genomics & Biotechnology ETF | GNOM | Amplify Transformational Data Sharing ETF | BLOK | Amplify BlackSwan Growth & Treasury Core ETF | SWAN | ETFMG Prime Junior Silver Miners ETF | SILJ | ETFMG Sit Ultra Short ETF | VALT | Global X Conscious Companies ETF | KRMA | Global X NASDAQ 100® Tail Risk ETF | QTR | Amplify BlackSwan ISWN ETF | ISWN | V-Shares US Leadership Diversity ETF | VDNI | Global X MSCI China Consumer Staples ETF | CHIS |
Gross Expense Ratio*
0.50%
SEC 30 Day Yield (as of 04/28/23 )
-0.33%
Ann. Dividend/Yield
No Regular Dividends
52-Wk Range
10.48 - 16.75
Fund Inception
04/05/2019
|
 Loading...
The chart is currently unavailable.
|
The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index ("underlying index").The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.
|
Market Return % (as of 04/30/2023) |
NAV Return % (as of 04/30/2023) |
Market Return % (as of 03/31/2023) |
NAV Return % (as of 03/31/2023) |
1-Month |
-0.49% |
-0.33% |
-2.45% |
-2.38% |
3-Month |
-9.72% |
-9.59% |
-2.61% |
-2.92% |
6-Month |
-6.77% |
-6.77% |
-1.83% |
-1.84% |
Year-to-date |
-3.08% |
-3.24% |
-2.61% |
-2.92% |
1-Year |
-3.77% |
-4.00% |
-18.03% |
-18.18% |
3-Year |
-5.45% |
-5.39% |
-0.32% |
-0.88% |
5-Year |
-- |
-- |
-- |
-- |
10-Year |
-- |
-- |
-- |
-- |
Since Inception |
-5.37% |
-5.25% |
-5.36% |
-5.28% |
Inception Date: April 05, 2019
Performance Details
Total return reflects performance without adjusting for sales charges or the effects of taxation, but is adjusted to reflect all actual ongoing fund expenses and assumes reinvestment of dividends and capital gains. If adjusted, sales charges would reduce the performance quoted. Performance data quoted represents past performance, is no guarantee of future results, and may not provide an adequate basis for evaluating the performance potential of the product over varying market conditions or economic cycles. Current performance may be higher or lower than the performance data quotes. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost.
|
Market Return % (as of 04/30/2023) |
NAV Return % (as of 04/30/2023) |
Market Return % (as of 03/31/2023) |
NAV Return % (as of 03/31/2023) |
1-Year |
-3.77% |
-4.00% |
-18.03% |
-18.18% |
5-Year |
-- |
-- |
-- |
-- |
10-Year |
-- |
-- |
-- |
-- |
Since Inception |
-5.37% |
-5.25% |
-5.36% |
-5.28% |
Inception Date: April 05, 2019
Cyclical |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Defensive |
100.00% |
0.00% |
100.00% |
0.00% |
Sensitive |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Portfolio Details
|
* represents an International company or one without a recognizable symbol.
Portfolio Details
|
|
|